カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の静脈内（IV）鉄剤市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Intraveno(IV) Iron Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19433）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19433
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：108
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の静脈内（IV）鉄剤市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

静脈内（IV）鉄剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の静脈内（IV）鉄剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

静脈内（IV）鉄剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・低分子デキストラン鉄、グルコン酸第二鉄、スクロース鉄、カルボキシルマルトース鉄

用途別セグメントは次のように区分されます。
・病院、外来手術センター、診断センター

世界の静脈内（IV）鉄剤市場の主要な市場プレーヤーは以下のとおりです。
・Allergan、AMAG Pharmaceuticals、Galenica、Actavis、American Regent、Sanofi、Luitpold Pharmaceuticals、Fresenius Medical Care、Pharmacosmos、Vifor Pharma

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、静脈内（IV）鉄剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な静脈内（IV）鉄剤メーカーの企業概要、2019年～2022年までの静脈内（IV）鉄剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な静脈内（IV）鉄剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別静脈内（IV）鉄剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの静脈内（IV）鉄剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での静脈内（IV）鉄剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および静脈内（IV）鉄剤の産業チェーンを掲載しています。
・第13、14、15章では、静脈内（IV）鉄剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 静脈内（IV）鉄剤の概要
- 種類別分析（2017年vs2021年vs2028年）：低分子デキストラン鉄、グルコン酸第二鉄、スクロース鉄、カルボキシルマルトース鉄
- 用途別分析（2017年vs2021年vs2028年）：病院、外来手術センター、診断センター
- 世界の静脈内（IV）鉄剤市場規模・予測
- 世界の静脈内（IV）鉄剤生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Allergan、AMAG Pharmaceuticals、Galenica、Actavis、American Regent、Sanofi、Luitpold Pharmaceuticals、Fresenius Medical Care、Pharmacosmos、Vifor Pharma
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：低分子デキストラン鉄、グルコン酸第二鉄、スクロース鉄、カルボキシルマルトース鉄
・用途別分析2017年-2028年：病院、外来手術センター、診断センター
・静脈内（IV）鉄剤の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・静脈内（IV）鉄剤のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・静脈内（IV）鉄剤のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・静脈内（IV）鉄剤の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・静脈内（IV）鉄剤の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Intraveno(IV) Iron Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Intraveno(IV) Iron Drugs market size is estimated to be worth US$ 1868.1 million in 2021 and is forecast to a readjusted size of USD 2648 million by 2028 with a CAGR of 5.1% during review period. Hospitals accounting for % of the Intraveno(IV) Iron Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Low Molecular Weight Iron Dextran segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Intraveno(IV) Iron Drugs include Allergan, AMAG Pharmaceuticals, Galenica, Actavis, and American Regent, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Intraveno(IV) Iron Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Low Molecular Weight Iron Dextran
Ferric Gluconate
Iron Sucrose
Ferric Carboxyl Maltose
Market segment by Application can be divided into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
The key market players for global Intraveno(IV) Iron Drugs market are listed below:
Allergan
AMAG Pharmaceuticals
Galenica
Actavis
American Regent
Sanofi
Luitpold Pharmaceuticals
Fresenius Medical Care
Pharmacosmos
Vifor Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intraveno(IV) Iron Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Intraveno(IV) Iron Drugs, with price, sales, revenue and global market share of Intraveno(IV) Iron Drugs from 2019 to 2022.
Chapter 3, the Intraveno(IV) Iron Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intraveno(IV) Iron Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Intraveno(IV) Iron Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Intraveno(IV) Iron Drugs.
Chapter 13, 14, and 15, to describe Intraveno(IV) Iron Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Intraveno(IV) Iron Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Intraveno(IV) Iron Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Low Molecular Weight Iron Dextran
1.2.3 Ferric Gluconate
1.2.4 Iron Sucrose
1.2.5 Ferric Carboxyl Maltose
1.3 Market Analysis by Application
1.3.1 Overview: Global Intraveno(IV) Iron Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Global Intraveno(IV) Iron Drugs Market Size & Forecast
1.4.1 Global Intraveno(IV) Iron Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Intraveno(IV) Iron Drugs Sales in Volume (2017-2028)
1.4.3 Global Intraveno(IV) Iron Drugs Price (2017-2028)
1.5 Global Intraveno(IV) Iron Drugs Production Capacity Analysis
1.5.1 Global Intraveno(IV) Iron Drugs Total Production Capacity (2017-2028)
1.5.2 Global Intraveno(IV) Iron Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Intraveno(IV) Iron Drugs Market Drivers
1.6.2 Intraveno(IV) Iron Drugs Market Restraints
1.6.3 Intraveno(IV) Iron Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business
2.1.3 Allergan Intraveno(IV) Iron Drugs Product and Services
2.1.4 Allergan Intraveno(IV) Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 AMAG Pharmaceuticals
2.2.1 AMAG Pharmaceuticals Details
2.2.2 AMAG Pharmaceuticals Major Business
2.2.3 AMAG Pharmaceuticals Intraveno(IV) Iron Drugs Product and Services
2.2.4 AMAG Pharmaceuticals Intraveno(IV) Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Galenica
2.3.1 Galenica Details
2.3.2 Galenica Major Business
2.3.3 Galenica Intraveno(IV) Iron Drugs Product and Services
2.3.4 Galenica Intraveno(IV) Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Actavis
2.4.1 Actavis Details
2.4.2 Actavis Major Business
2.4.3 Actavis Intraveno(IV) Iron Drugs Product and Services
2.4.4 Actavis Intraveno(IV) Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 American Regent
2.5.1 American Regent Details
2.5.2 American Regent Major Business
2.5.3 American Regent Intraveno(IV) Iron Drugs Product and Services
2.5.4 American Regent Intraveno(IV) Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Intraveno(IV) Iron Drugs Product and Services
2.6.4 Sanofi Intraveno(IV) Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Luitpold Pharmaceuticals
2.7.1 Luitpold Pharmaceuticals Details
2.7.2 Luitpold Pharmaceuticals Major Business
2.7.3 Luitpold Pharmaceuticals Intraveno(IV) Iron Drugs Product and Services
2.7.4 Luitpold Pharmaceuticals Intraveno(IV) Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Fresenius Medical Care
2.8.1 Fresenius Medical Care Details
2.8.2 Fresenius Medical Care Major Business
2.8.3 Fresenius Medical Care Intraveno(IV) Iron Drugs Product and Services
2.8.4 Fresenius Medical Care Intraveno(IV) Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Pharmacosmos
2.9.1 Pharmacosmos Details
2.9.2 Pharmacosmos Major Business
2.9.3 Pharmacosmos Intraveno(IV) Iron Drugs Product and Services
2.9.4 Pharmacosmos Intraveno(IV) Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Vifor Pharma
2.10.1 Vifor Pharma Details
2.10.2 Vifor Pharma Major Business
2.10.3 Vifor Pharma Intraveno(IV) Iron Drugs Product and Services
2.10.4 Vifor Pharma Intraveno(IV) Iron Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Intraveno(IV) Iron Drugs Breakdown Data by Manufacturer
3.1 Global Intraveno(IV) Iron Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Intraveno(IV) Iron Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Intraveno(IV) Iron Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Intraveno(IV) Iron Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Intraveno(IV) Iron Drugs Manufacturer Market Share in 2021
3.5 Global Intraveno(IV) Iron Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Intraveno(IV) Iron Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Intraveno(IV) Iron Drugs Market Size by Region
4.1.1 Global Intraveno(IV) Iron Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Intraveno(IV) Iron Drugs Revenue by Region (2017-2028)
4.2 North America Intraveno(IV) Iron Drugs Revenue (2017-2028)
4.3 Europe Intraveno(IV) Iron Drugs Revenue (2017-2028)
4.4 Asia-Pacific Intraveno(IV) Iron Drugs Revenue (2017-2028)
4.5 South America Intraveno(IV) Iron Drugs Revenue (2017-2028)
4.6 Middle East and Africa Intraveno(IV) Iron Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Intraveno(IV) Iron Drugs Sales in Volume by Type (2017-2028)
5.2 Global Intraveno(IV) Iron Drugs Revenue by Type (2017-2028)
5.3 Global Intraveno(IV) Iron Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Intraveno(IV) Iron Drugs Sales in Volume by Application (2017-2028)
6.2 Global Intraveno(IV) Iron Drugs Revenue by Application (2017-2028)
6.3 Global Intraveno(IV) Iron Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Intraveno(IV) Iron Drugs Sales by Type (2017-2028)
7.2 North America Intraveno(IV) Iron Drugs Sales by Application (2017-2028)
7.3 North America Intraveno(IV) Iron Drugs Market Size by Country
7.3.1 North America Intraveno(IV) Iron Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Intraveno(IV) Iron Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Intraveno(IV) Iron Drugs Sales by Type (2017-2028)
8.2 Europe Intraveno(IV) Iron Drugs Sales by Application (2017-2028)
8.3 Europe Intraveno(IV) Iron Drugs Market Size by Country
8.3.1 Europe Intraveno(IV) Iron Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Intraveno(IV) Iron Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Intraveno(IV) Iron Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Intraveno(IV) Iron Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Intraveno(IV) Iron Drugs Market Size by Region
9.3.1 Asia-Pacific Intraveno(IV) Iron Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Intraveno(IV) Iron Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Intraveno(IV) Iron Drugs Sales by Type (2017-2028)
10.2 South America Intraveno(IV) Iron Drugs Sales by Application (2017-2028)
10.3 South America Intraveno(IV) Iron Drugs Market Size by Country
10.3.1 South America Intraveno(IV) Iron Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Intraveno(IV) Iron Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Intraveno(IV) Iron Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Intraveno(IV) Iron Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Intraveno(IV) Iron Drugs Market Size by Country
11.3.1 Middle East & Africa Intraveno(IV) Iron Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Intraveno(IV) Iron Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Intraveno(IV) Iron Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Intraveno(IV) Iron Drugs
12.3 Intraveno(IV) Iron Drugs Production Process
12.4 Intraveno(IV) Iron Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Intraveno(IV) Iron Drugs Typical Distributors
13.3 Intraveno(IV) Iron Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Intraveno(IV) Iron Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Intraveno(IV) Iron Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Allergan Basic Information, Manufacturing Base and Competitors
Table 4. Allergan Major Business
Table 5. Allergan Intraveno(IV) Iron Drugs Product and Services
Table 6. Allergan Intraveno(IV) Iron Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. AMAG Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. AMAG Pharmaceuticals Major Business
Table 9. AMAG Pharmaceuticals Intraveno(IV) Iron Drugs Product and Services
Table 10. AMAG Pharmaceuticals Intraveno(IV) Iron Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Galenica Basic Information, Manufacturing Base and Competitors
Table 12. Galenica Major Business
Table 13. Galenica Intraveno(IV) Iron Drugs Product and Services
Table 14. Galenica Intraveno(IV) Iron Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Actavis Basic Information, Manufacturing Base and Competitors
Table 16. Actavis Major Business
Table 17. Actavis Intraveno(IV) Iron Drugs Product and Services
Table 18. Actavis Intraveno(IV) Iron Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. American Regent Basic Information, Manufacturing Base and Competitors
Table 20. American Regent Major Business
Table 21. American Regent Intraveno(IV) Iron Drugs Product and Services
Table 22. American Regent Intraveno(IV) Iron Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi Intraveno(IV) Iron Drugs Product and Services
Table 26. Sanofi Intraveno(IV) Iron Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Luitpold Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Luitpold Pharmaceuticals Major Business
Table 29. Luitpold Pharmaceuticals Intraveno(IV) Iron Drugs Product and Services
Table 30. Luitpold Pharmaceuticals Intraveno(IV) Iron Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Fresenius Medical Care Basic Information, Manufacturing Base and Competitors
Table 32. Fresenius Medical Care Major Business
Table 33. Fresenius Medical Care Intraveno(IV) Iron Drugs Product and Services
Table 34. Fresenius Medical Care Intraveno(IV) Iron Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Pharmacosmos Basic Information, Manufacturing Base and Competitors
Table 36. Pharmacosmos Major Business
Table 37. Pharmacosmos Intraveno(IV) Iron Drugs Product and Services
Table 38. Pharmacosmos Intraveno(IV) Iron Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Vifor Pharma Basic Information, Manufacturing Base and Competitors
Table 40. Vifor Pharma Major Business
Table 41. Vifor Pharma Intraveno(IV) Iron Drugs Product and Services
Table 42. Vifor Pharma Intraveno(IV) Iron Drugs Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Intraveno(IV) Iron Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
Table 44. Global Intraveno(IV) Iron Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Intraveno(IV) Iron Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Intraveno(IV) Iron Drugs Production Capacity by Company, (K MT): 2020 VS 2021
Table 47. Head Office and Intraveno(IV) Iron Drugs Production Site of Key Manufacturer
Table 48. Intraveno(IV) Iron Drugs New Entrant and Capacity Expansion Plans
Table 49. Intraveno(IV) Iron Drugs Mergers & Acquisitions in the Past Five Years
Table 50. Global Intraveno(IV) Iron Drugs Sales by Region (2017-2022) & (K MT)
Table 51. Global Intraveno(IV) Iron Drugs Sales by Region (2023-2028) & (K MT)
Table 52. Global Intraveno(IV) Iron Drugs Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Intraveno(IV) Iron Drugs Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Intraveno(IV) Iron Drugs Sales by Type (2017-2022) & (K MT)
Table 55. Global Intraveno(IV) Iron Drugs Sales by Type (2023-2028) & (K MT)
Table 56. Global Intraveno(IV) Iron Drugs Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Intraveno(IV) Iron Drugs Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Intraveno(IV) Iron Drugs Price by Type (2017-2022) & (USD/MT)
Table 59. Global Intraveno(IV) Iron Drugs Price by Type (2023-2028) & (USD/MT)
Table 60. Global Intraveno(IV) Iron Drugs Sales by Application (2017-2022) & (K MT)
Table 61. Global Intraveno(IV) Iron Drugs Sales by Application (2023-2028) & (K MT)
Table 62. Global Intraveno(IV) Iron Drugs Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Intraveno(IV) Iron Drugs Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Intraveno(IV) Iron Drugs Price by Application (2017-2022) & (USD/MT)
Table 65. Global Intraveno(IV) Iron Drugs Price by Application (2023-2028) & (USD/MT)
Table 66. North America Intraveno(IV) Iron Drugs Sales by Country (2017-2022) & (K MT)
Table 67. North America Intraveno(IV) Iron Drugs Sales by Country (2023-2028) & (K MT)
Table 68. North America Intraveno(IV) Iron Drugs Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Intraveno(IV) Iron Drugs Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Intraveno(IV) Iron Drugs Sales by Type (2017-2022) & (K MT)
Table 71. North America Intraveno(IV) Iron Drugs Sales by Type (2023-2028) & (K MT)
Table 72. North America Intraveno(IV) Iron Drugs Sales by Application (2017-2022) & (K MT)
Table 73. North America Intraveno(IV) Iron Drugs Sales by Application (2023-2028) & (K MT)
Table 74. Europe Intraveno(IV) Iron Drugs Sales by Country (2017-2022) & (K MT)
Table 75. Europe Intraveno(IV) Iron Drugs Sales by Country (2023-2028) & (K MT)
Table 76. Europe Intraveno(IV) Iron Drugs Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Intraveno(IV) Iron Drugs Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Intraveno(IV) Iron Drugs Sales by Type (2017-2022) & (K MT)
Table 79. Europe Intraveno(IV) Iron Drugs Sales by Type (2023-2028) & (K MT)
Table 80. Europe Intraveno(IV) Iron Drugs Sales by Application (2017-2022) & (K MT)
Table 81. Europe Intraveno(IV) Iron Drugs Sales by Application (2023-2028) & (K MT)
Table 82. Asia-Pacific Intraveno(IV) Iron Drugs Sales by Region (2017-2022) & (K MT)
Table 83. Asia-Pacific Intraveno(IV) Iron Drugs Sales by Region (2023-2028) & (K MT)
Table 84. Asia-Pacific Intraveno(IV) Iron Drugs Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Intraveno(IV) Iron Drugs Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Intraveno(IV) Iron Drugs Sales by Type (2017-2022) & (K MT)
Table 87. Asia-Pacific Intraveno(IV) Iron Drugs Sales by Type (2023-2028) & (K MT)
Table 88. Asia-Pacific Intraveno(IV) Iron Drugs Sales by Application (2017-2022) & (K MT)
Table 89. Asia-Pacific Intraveno(IV) Iron Drugs Sales by Application (2023-2028) & (K MT)
Table 90. South America Intraveno(IV) Iron Drugs Sales by Country (2017-2022) & (K MT)
Table 91. South America Intraveno(IV) Iron Drugs Sales by Country (2023-2028) & (K MT)
Table 92. South America Intraveno(IV) Iron Drugs Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Intraveno(IV) Iron Drugs Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Intraveno(IV) Iron Drugs Sales by Type (2017-2022) & (K MT)
Table 95. South America Intraveno(IV) Iron Drugs Sales by Type (2023-2028) & (K MT)
Table 96. South America Intraveno(IV) Iron Drugs Sales by Application (2017-2022) & (K MT)
Table 97. South America Intraveno(IV) Iron Drugs Sales by Application (2023-2028) & (K MT)
Table 98. Middle East & Africa Intraveno(IV) Iron Drugs Sales by Region (2017-2022) & (K MT)
Table 99. Middle East & Africa Intraveno(IV) Iron Drugs Sales by Region (2023-2028) & (K MT)
Table 100. Middle East & Africa Intraveno(IV) Iron Drugs Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Intraveno(IV) Iron Drugs Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Intraveno(IV) Iron Drugs Sales by Type (2017-2022) & (K MT)
Table 103. Middle East & Africa Intraveno(IV) Iron Drugs Sales by Type (2023-2028) & (K MT)
Table 104. Middle East & Africa Intraveno(IV) Iron Drugs Sales by Application (2017-2022) & (K MT)
Table 105. Middle East & Africa Intraveno(IV) Iron Drugs Sales by Application (2023-2028) & (K MT)
Table 106. Intraveno(IV) Iron Drugs Raw Material
Table 107. Key Manufacturers of Intraveno(IV) Iron Drugs Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Intraveno(IV) Iron Drugs Typical Distributors
Table 111. Intraveno(IV) Iron Drugs Typical Customers
List of Figures
Figure 1. Intraveno(IV) Iron Drugs Picture
Figure 2. Global Intraveno(IV) Iron Drugs Revenue Market Share by Type in 2021
Figure 3. Low Molecular Weight Iron Dextran
Figure 4. Ferric Gluconate
Figure 5. Iron Sucrose
Figure 6. Ferric Carboxyl Maltose
Figure 7. Global Intraveno(IV) Iron Drugs Revenue Market Share by Application in 2021
Figure 8. Hospitals
Figure 9. Ambulatory Surgical Centers
Figure 10. Diagnostic Centers
Figure 11. Global Intraveno(IV) Iron Drugs Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
Figure 12. Global Intraveno(IV) Iron Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Intraveno(IV) Iron Drugs Sales (2017-2028) & (K MT)
Figure 14. Global Intraveno(IV) Iron Drugs Price (2017-2028) & (USD/MT)
Figure 15. Global Intraveno(IV) Iron Drugs Production Capacity (2017-2028) & (K MT)
Figure 16. Global Intraveno(IV) Iron Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Intraveno(IV) Iron Drugs Market Drivers
Figure 18. Intraveno(IV) Iron Drugs Market Restraints
Figure 19. Intraveno(IV) Iron Drugs Market Trends
Figure 20. Global Intraveno(IV) Iron Drugs Sales Market Share by Manufacturer in 2021
Figure 21. Global Intraveno(IV) Iron Drugs Revenue Market Share by Manufacturer in 2021
Figure 22. Intraveno(IV) Iron Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Intraveno(IV) Iron Drugs Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Intraveno(IV) Iron Drugs Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Intraveno(IV) Iron Drugs Sales Market Share by Region (2017-2028)
Figure 26. Global Intraveno(IV) Iron Drugs Revenue Market Share by Region (2017-2028)
Figure 27. North America Intraveno(IV) Iron Drugs Revenue (2017-2028) & (USD Million)
Figure 28. Europe Intraveno(IV) Iron Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Intraveno(IV) Iron Drugs Revenue (2017-2028) & (USD Million)
Figure 30. South America Intraveno(IV) Iron Drugs Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Intraveno(IV) Iron Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Global Intraveno(IV) Iron Drugs Sales Market Share by Type (2017-2028)
Figure 33. Global Intraveno(IV) Iron Drugs Revenue Market Share by Type (2017-2028)
Figure 34. Global Intraveno(IV) Iron Drugs Price by Type (2017-2028) & (USD/MT)
Figure 35. Global Intraveno(IV) Iron Drugs Sales Market Share by Application (2017-2028)
Figure 36. Global Intraveno(IV) Iron Drugs Revenue Market Share by Application (2017-2028)
Figure 37. Global Intraveno(IV) Iron Drugs Price by Application (2017-2028) & (USD/MT)
Figure 38. North America Intraveno(IV) Iron Drugs Sales Market Share by Type (2017-2028)
Figure 39. North America Intraveno(IV) Iron Drugs Sales Market Share by Application (2017-2028)
Figure 40. North America Intraveno(IV) Iron Drugs Sales Market Share by Country (2017-2028)
Figure 41. North America Intraveno(IV) Iron Drugs Revenue Market Share by Country (2017-2028)
Figure 42. United States Intraveno(IV) Iron Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Intraveno(IV) Iron Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Intraveno(IV) Iron Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Intraveno(IV) Iron Drugs Sales Market Share by Type (2017-2028)
Figure 46. Europe Intraveno(IV) Iron Drugs Sales Market Share by Application (2017-2028)
Figure 47. Europe Intraveno(IV) Iron Drugs Sales Market Share by Country (2017-2028)
Figure 48. Europe Intraveno(IV) Iron Drugs Revenue Market Share by Country (2017-2028)
Figure 49. Germany Intraveno(IV) Iron Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Intraveno(IV) Iron Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Intraveno(IV) Iron Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Intraveno(IV) Iron Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Intraveno(IV) Iron Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Intraveno(IV) Iron Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Intraveno(IV) Iron Drugs Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Intraveno(IV) Iron Drugs Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Intraveno(IV) Iron Drugs Revenue Market Share by Region (2017-2028)
Figure 58. China Intraveno(IV) Iron Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Intraveno(IV) Iron Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Intraveno(IV) Iron Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Intraveno(IV) Iron Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Intraveno(IV) Iron Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Intraveno(IV) Iron Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Intraveno(IV) Iron Drugs Sales Market Share by Type (2017-2028)
Figure 65. South America Intraveno(IV) Iron Drugs Sales Market Share by Application (2017-2028)
Figure 66. South America Intraveno(IV) Iron Drugs Sales Market Share by Country (2017-2028)
Figure 67. South America Intraveno(IV) Iron Drugs Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Intraveno(IV) Iron Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Intraveno(IV) Iron Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Intraveno(IV) Iron Drugs Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Intraveno(IV) Iron Drugs Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Intraveno(IV) Iron Drugs Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Intraveno(IV) Iron Drugs Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Intraveno(IV) Iron Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Intraveno(IV) Iron Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Intraveno(IV) Iron Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Intraveno(IV) Iron Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Intraveno(IV) Iron Drugs in 2021
Figure 79. Manufacturing Process Analysis of Intraveno(IV) Iron Drugs
Figure 80. Intraveno(IV) Iron Drugs Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のオシメルチニブ医薬品市場2022年：市場規模予測（～2028年）
  • 世界のエクセナチド薬物市場2022年：市場規模予測（～2028年）
  • 世界のペガスパルガーゼ薬物市場2022年：市場規模予測（～2028年）
  • 世界のリロナセプト薬物市場2022年：市場規模予測（～2028年）
  • 世界のブリナツモマブ治療薬市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19433 )"世界の静脈内（IV）鉄剤市場2022年：市場規模予測（～2028年）" (英文：Global Intraveno(IV) Iron Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。